Compare Kenvue Inc. Common Stock (KVUE) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kenvue Inc. Common Stock vs GeneDx Holdings Corp — how do they compare? Kenvue Inc. Common Stock trades at $17.64 (market cap $34.06B), while GeneDx Holdings Corp trades at $67.29 (market cap $2.02B). The key difference: Kenvue Inc. Common Stock is far larger — about 16.9× GeneDx Holdings Corp's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| KVUE | WGS | |
|---|---|---|
Market Cap | $34.06B | $2.02B |
Volume | 23,267,228 | 734,640 |
Sector | Consumer Staples | Health |
52-Week High | $19.83 | $167.51 |
52-Week Low | $14.11 | $34.51 |
Enterprise Value | $41.56B | $2.05B |
Dividend Yield | 4.74% | — |
Typical Hold Time | — | 19 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
GeneDx (WGS) trades at $68.09, down 0.64% today, with a bearish technical signal despite bullish oscillators showing oversold conditions. The company reported mixed Q2 2026 results with revenue beating expectations but negative profitability metrics, including a -23.4% net income margin. Recent news highlights product launches and industry recognition, while analyst consensus remains strongly bullish with a $81 price target.
The stock presents a growth opportunity in genomic testing with strong analyst support, but faces significant execution risks from persistent losses and high valuation multiples. Key catalysts include continued revenue growth and path to profitability, while risks include competitive pressures and cash flow challenges from negative operating cash flow in 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kenvue Inc. Common Stock
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
